Based on the ONCOMINE database analysis, we found that the SEC61G gene was highly expressed in many types of tumors, such as brain/CNS cancer, head and neck cancer, and kidney cancer, compared with its expression in normal control tissues (Fig. 1d). This evidence concerns the gene SEC61G and central nervous system cancer.